According to CTI BioPharma 's latest financial reports the company's current revenue (TTM ) is โน6.80 Billion. In 2022 the company made a revenue of โน4.46 Billion an increase over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.